Form ARS Intellia Therapeutics, For: Dec 31
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Reiterates Buy Rating on Intellia Therapeutics (NTLA)
- TechnipFMC Awarded Flexible Pipe Contract for Azule’s Greater PAJ Project
- As U.S. Multifamily Construction Hits a Six-Year Low, One of Cleveland's Largest Residential Projects Is Delivering Anyway
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
